Ask Congress to Ensure Access to FDA-Approved Alzheimer’s Treatments
CMS must reverse its unprecedented decision blocking access to current and future Alzheimer’s treatments. Urge Congress to help ensure full access to FDA-approved Alzheimer’s treatments.
Be a Champion in the Fight to End Alzheimer’s
Our voices are stronger together. Help AIM advance legislation to improve the lives of people impacted by Alzheimer’s and all other dementia.
- Share your story with elected officials
- Engage on social media
- Write a letter to the editor
Nationwide State Priorities
AIM is working with state lawmakers to implement policies to improve the lives of people living with Alzheimer’s and other dementia, and their caregivers. Explore the issues.
A National Response to Alzheimer’s and Other Dementia
The bipartisan NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act would build on the progress made over the last decade by continuing to promote rapid research and improve the delivery of clinical care and services for people living with Alzheimer’s.
A Path to Better Dementia Care
The bipartisan Comprehensive Care for Alzheimer’s Act would ask the Center for Medicare & Medicaid Innovation (CMMI) to test a different payment structure for dementia care management. This important bill has the potential to streamline today’s complicated health care maze for people living with dementia and their caregivers.
Your Guide to Advocacy
Here’s everything you need to make the most of your year-round advocacy efforts to improve the lives of those impacted by Alzheimer’s and all other dementia. This guide will be updated throughout the year as our policy priorities are introduced and advanced.
Progress in the Fight Against Alzheimer’s
Since its founding in 2010, AIM, the Alzheimer’s Association and our advocates have been unrelenting in our fight for a world without Alzheimer’s and all other dementia. By securing robust increases for Alzheimer’s and dementia research funding and advancing critical legislation, we have made a positive and meaningful impact on people living with Alzheimer’s and their caregivers.
Alzheimer’s Advocates Turn House Budget Hearings Purple, Building Bipartisan Momentum for Access to FDA-Approved Alzheimer’s Treatments
Alzheimer’s Association and Advocates Urge HHS Secretary to Cover Alzheimer’s Treatments Washington, D.C., March 29, 2023 — Alzheimer’s Association advocates put on their purple and came together i...